7 results
P.014 Eptinezumab improved work productivity in adults with migraine and prior preventive treatment failures: results from the DELIVER study
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 50 / Issue s2 / June 2023
- Published online by Cambridge University Press:
- 05 June 2023, p. S61
-
- Article
-
- You have access
- Export citation
P.016 Impact of eptinezumab on patient-reported outcomes in patients with prior preventive treatment failures
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 50 / Issue s2 / June 2023
- Published online by Cambridge University Press:
- 05 June 2023, p. S61
-
- Article
-
- You have access
- Export citation
P.017 Optimization of acute treatment and headache-related impact following eptinezumab initiated during a migraine attack: post hoc analysis of the RELIEF study
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 49 / Issue s1 / June 2022
- Published online by Cambridge University Press:
- 24 June 2022, p. S12
-
- Article
-
- You have access
- Export citation
P.016 Reduction in migraine-associated burden over 24 weeks of treatment with eptinezumab in patients with chronic migraine
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 49 / Issue s1 / June 2022
- Published online by Cambridge University Press:
- 24 June 2022, pp. S11-S12
-
- Article
-
- You have access
- Export citation
P.027 Efficacy and Safety of Eptinezumab Initiated During a Migraine Attack: Results from the RELIEF Study
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 48 / Issue s3 / November 2021
- Published online by Cambridge University Press:
- 05 January 2022, pp. S27-S28
-
- Article
-
- You have access
- Export citation
The impact of dose on the real-world effectiveness of vortioxetine in outpatients with mdd in greece
-
- Journal:
- European Psychiatry / Volume 64 / Issue S1 / April 2021
- Published online by Cambridge University Press:
- 13 August 2021, pp. S337-S338
-
- Article
-
- You have access
- Open access
- Export citation
Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study
-
- Journal:
- CNS Spectrums / Volume 24 / Issue 6 / December 2019
- Published online by Cambridge University Press:
- 25 February 2019, pp. 616-627
-
- Article
-
- You have access
- Open access
- HTML
- Export citation